Wealthspan Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wealthspan Partners's LLY Position: Q2 2026 in Review
Wealthspan Partners increased its Eli Lilly (LLY) stake by 0.43% in Q2 2026, buying an estimated $9.2K and bringing the position to 2,120 shares worth $2.54M. The position accounts for 0.8% of the portfolio, ranked #30.
Wealthspan Partners first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Wealthspan Partners held 2,120 shares of Eli Lilly worth $2.54M as of Q2 2026.
- Wealthspan Partners bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
- Eli Lilly made up 0.8% of Wealthspan Partners's portfolio in Q2 2026, its #30 holding.
- Wealthspan Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Wealthspan Partners's 13F filing for Q2 2026, filed 6 Aug 2026.